Description

Semaglutide and Tirzepatide: GLP-1 (Glucagon-Like Peptide-1) is a hormone that plays a significant role in weight management by affecting appetite, digestion, and the body’s energy balance. Here’s how it works to help with weight loss:

1. Reduces Appetite: GLP-1 acts on specific areas of the brain that regulate hunger, helping to reduce the feeling of hunger and decrease the desire to eat. This means you’re less likely to overeat or snack between meals, which can lead to a reduction in overall calorie intake.
2. Slows Gastric Emptying: GLP-1 slows down the rate at which food leaves your stomach, which prolongs the sensation of fullness after eating. When you feel full for a longer period, it reduces the urge to eat frequently, further supporting calorie reduction.
3. Promotes Satiety: By enhancing feelings of satiety (the sense of being satisfied after eating), GLP-1 helps you feel content with smaller portions of food. This can be particularly beneficial for those who struggle with portion control or emotional eating.
4. Regulates Blood Sugar Levels: By improving insulin secretion and controlling blood sugar levels, GLP-1 helps prevent blood sugar spikes and crashes that can trigger cravings for sugary or high-calorie foods. Stable blood sugar levels contribute to a more balanced appetite.
5.  Supports Fat Metabolism: GLP-1 may also have a role in enhancing fat metabolism. By promoting better insulin sensitivity and glucose utilization, it helps the body more efficiently use stored fat as energy, contributing to weight loss over time.
6.  Regenerates Neurons & Tissues: GLP-1 has anti-inflammatory properties that can protect neurons from damage caused by chronic inflammation. This neuroprotective effect helps prevent neuron death and supports the brain’s ability to repair itself.

In basic terms, this is a once weekly injection performed in the privacy of your home. As described above, the hormone signals the brain to feel full and content after eating. With the steady supply of this hormone patients receive signals to the brain telling them that they are full after eating much smaller portions.

The half life of Semaglutide and Tirzepatide is 6.6 days. This means that the appetite suppressant can last for a week in our body rather than minutes. It is administered once per week in the comfort of your home via a subcutaneous injection. Patients can expect an average weight loss of 15-20%.

Disclaimer: BMI under 27% will not be treated. Labs required prior to acceptance into the program